Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Merck
Fish and Richardson
Deloitte
Novartis
Harvard Business School
McKinsey
Queensland Health
Federal Trade Commission
Colorcon

Generated: August 17, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title:Topical nepafenac formulations
Abstract:Topical suspension compositions of nepafenac are disclosed. The compositions are especially suitable for topical ophthalmic administration.
Inventor(s): Wong; Warren (Fort Worth, TX)
Assignee: Alcon, Inc. (Hunenberg, CH)
Application Number:11/292,484
Patent Claims: 1. A method of treating ophthalmic inflammatory disorders in a human patient comprising topically administering to the patient a composition consisting of a) 0.1% (w/v) nepafenac; b) 0.5% (w/v) carbomer; c) 0.01% (w/v) tyloxapol; d) 0.4% (w/v) sodium chloride; e) 2.4% (w/v) mannitol; f) a pH-adjusting agent in an amount sufficient to cause the composition to have a pH of 7.3-7.7; g) 0.005% (w/v) benzalkonium chloride; h) 0.01% edetate disodium; and i) purified water.

2. In a method of treating ophthalmic inflammatory disorders in a human patient comprising topically administering to the patient an aqueous suspension composition comprising nepafenac, the improvement wherein the composition consists of a) 0.1% (w/v) nepafenac; b) 0.5% (w/v) carbomer; c) 0.01% (w/v) tyloxapol; d) 0.4% (w/v) sodium chloride; e) 2.4% (w/v) mannitol; f) a pH-adjusting agent in an amount sufficient to cause the composition to have a pH of 7.3-7.7; g) 0.005% (w/v) benzalkonium chloride; h) 0.01% edetate disodium; and i) purified water.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
UBS
Novartis
US Department of Justice
QuintilesIMS
Argus Health
Accenture
Covington
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot